The content relates to an enterprise taxonomy focused on Digital Health, encompassing areas like Population and Public Health and Technology Care. Additionally, it mentions node settings that exclude this information from the Accelerate RSS feed.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
